openPR Logo
Press release

GenomicTree Inc Product Pipeline Analysis Report - Pharmaceutical and Diagnostic Sector Report (2017)

06-06-2017 03:23 PM CET | Health & Medicine

Press release from: Medical Industry Research Reports - MRH

Market Research Hub

Market Research Hub

Market Research Hub’s announced a report on GenomicTree Inc Product Pipeline Analysis. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products, and brands. This report also enhances decision-making capabilities and help to create effective counter-strategies to gain competitive advantage.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1107614

GenomicTree Inc (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung and bladder cancer. GenomicTree's products include novel epigenetic biomarkers and non-invasive accurate cancer detection products. The company's other products comprise infectious diseases detection products, genotypes detection products, methylation profiling systems, single tube products, oncology treatment products, and others. It offers services such as assay development, clinical validation, gene expression microarray services, miRNA microarray, methylation microarray, pyrosequencing, methylation and methylation assay services. The company caters to pharmaceutical and diagnostic sectors. GenomicTree is headquartered in Daejeon, South Korea.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GenomicTree Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/genomictree-inc-product-pipeline-analysis-2017-update-report.html

Table of Contents:
Table of Contents 2
List of Tables 3
List of Figures 3
GenomicTree Inc Company Overview 4
GenomicTree Inc Company Snapshot 4
GenomicTree Inc Pipeline Products and Ongoing Clinical Trials Overview 4
GenomicTree Inc Pipeline Analysis Overview 7
GenomicTree Inc - Key Facts 7
GenomicTree Inc - Major Products and Services 8
GenomicTree Inc Pipeline Products by Development Stage 9
GenomicTree Inc Pipeline Products Overview 11
ASRP BRAF V600E PCR Assay 11
ASRP BRAF V600E PCR Assay Product Overview 11
ASRP KRAS Multiplex PCR Assay 12
ASRP KRAS Multiplex PCR Assay Product Overview 12
EarlyTect - Bladder Cancer 13
EarlyTect - Bladder Cancer Product Overview 13
EarlyTect - Lung Cancer 14
EarlyTect - Lung Cancer Product Overview 14
EarlyTect Breast Cancer 15
EarlyTect Breast Cancer Product Overview 15
EarlyTect Cervical Cancer 16
EarlyTect Cervical Cancer Product Overview 16
EarlyTect Colon Cancer 17
EarlyTect Colon Cancer Product Overview 17
EarlyTect Colorectal Cancer - Recurrence 18
EarlyTect Colorectal Cancer - Recurrence Product Overview 18

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub/
LinkedIn: https://www.linkedin.com/company/market-research-hub/
Facebook: https://www.facebook.com/MarketResearchHub/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GenomicTree Inc Product Pipeline Analysis Report - Pharmaceutical and Diagnostic Sector Report (2017) here

News-ID: 563176 • Views:

More Releases from Medical Industry Research Reports - MRH

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Reviewed, H1, 2017: Pharmaceutical Reports
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Report includes an overview of trial numbers and their average enrollment
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, H1, 2017: Market Research Hub Reports
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Liver Disease Global Clinical Trials Reviewed H1 – 2017: Pharmaceuticals & Healthcare Reports
Chronic Liver Disease Global Clinical Trials Reviewed H1 – 2017: Pharmaceutica …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Liver Disease Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Liver Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review H1 – 2017: Market Research Hub Reports
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review H1 – 2017: Ma …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries

All 5 Releases


More Releases for GenomicTree

Early Cancer Screening Products Market to Witness Huge Growth by Key Players: EX …
The Early Cancer Screening Products market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Early Cancer Screening Products report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The Early Cancer Screening Products research report also provides
What's driving the Genetic Testing Market growth? Abbott Molecular, Bayer Diagno …
The Genetic Testing Market report has been evaluated in terms of the latest technology, business rivals, strategies adopted by industry players, important firms, growth rate and projections until the year 2025. The report is inclusive of substantial information that concentrates on bringing to the fore, the most significant sectors of market. Based on the research, the size of the overall Genetic Testing Market was recorded at USD 11.8 billion in the
Global Genetic Testing Market Share 2025 Analysis By Top Abbott Molecular, Bayer …
MarketStudyReport.com Adds New Report Genetic Testing Market 2019 - 2025 research report providing information and data By Test Type, By Application, Regional Outlook, Growth Potential, Competitive Market Share & Forecast spreading across 140 Pages with table and figures in it. Availability of new tests owing to technological advancements in the field of genetic testing will serve to be high impact rendering factor. Demand for genetic testing is increasing due to the
Genetic Testing Market Key Information By Top Key Player Abbott Molecular, Bayer …
Market Study Report recently introduced new title on “2018-2024 Global Genetic Testing Market Report” that provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2024. Increasing prevalence of cancer and other genetic diseases worldwide will drive industry growth over the forecast timeframe. Breast cancer is the second leading cause of cancer deaths among women. According to the Pan American Health
Genetic Testing Market Emerging Trends Analysis For Top Key Players Like BioMeri …
Market Study Report adds global Genetic Testing Market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years. Genetic Testing Market will reach USD 22.5 billion by 2024. Diagnostic testing dominated the genetic testing market and accounted for USD 5,690.6 million in 2017. Request a Sample of this premium Research Report@ https://www.marketstudyreport.com/request-a-sample/1130965/ It
Genetic Testing Market Latest Research On Top Key Players like Celera Genomics, …
Market Study Report Adds Latest Genetic Testing Market dynamics, forces, companies and trends have been determined after conducting a detailed study of the industry for this newly released research report. It is expected to witness robust growth during the forecast period attributable to the increasing prevalence of chronic diseases worldwide. Diagnostic testing enables early diagnosis of diseases allowing patients to undergo timely therapeutic treatment, lower the severity of diseases and